These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8024566)

  • 1. Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis.
    Iida Y; Miyata T; Inagi R; Sugiyama S; Maeda K
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1235-41. PubMed ID: 8024566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
    Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
    J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
    Miyata T; Oda O; Inagi R; Iida Y; Araki N; Yamada N; Horiuchi S; Taniguchi N; Maeda K; Kinoshita T
    J Clin Invest; 1993 Sep; 92(3):1243-52. PubMed ID: 8376584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
    Miyata T
    Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycation of human beta 2-microglobulin in patients with hemodialysis-associated amyloidosis: identification of the glycated sites.
    Miyata T; Inagi R; Wada Y; Ueda Y; Iida Y; Takahashi M; Taniguchi N; Maeda K
    Biochemistry; 1994 Oct; 33(40):12215-21. PubMed ID: 7918443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis.
    Rashid G; Korzets Z; Bernheim J
    Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte/macrophage response to beta 2-microglobulin modified with advanced glycation end products.
    Miyata T; Iida Y; Ueda Y; Shinzato T; Seo H; Monnier VM; Maeda K; Wada Y
    Kidney Int; 1996 Feb; 49(2):538-50. PubMed ID: 8821842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous and lingual papules as a sign of beta 2 microglobulin-derived amyloidosis in a long-term hemodialysis patient.
    Uenotsuchi T; Imafuku S; Nagata M; Kiryu H; Morita K; Koga T; Furue M
    Eur J Dermatol; 2003; 13(4):393-5. PubMed ID: 12948922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts.
    Owen WF; Hou FF; Stuart RO; Kay J; Boyce J; Chertow GM; Schmidt AM
    Kidney Int; 1998 May; 53(5):1365-73. PubMed ID: 9573554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
    Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
    J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
    Gejyo F; Homma N; Arakawa M
    Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis related amyloidosis: a disease of chronic retention and inflammation?
    Floege J; Schäffer J; Koch KM; Shaldon S
    Kidney Int Suppl; 1992 Oct; 38():S78-85. PubMed ID: 1405384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mediators of amyloidogenesis and cytokines in dialysis-related amyloidosis].
    Rysavá R; Merta M; Tesar V; Lachmanová J; Sulková S; Bláha J
    Cas Lek Cesk; 2002 Apr; 141(8):244-7. PubMed ID: 12038073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis.
    Matsuo K; Ikizler TA; Hoover RL; Nakamoto M; Yasunaga C; Pupim LB; Hakim RM
    Kidney Int; 2000 Feb; 57(2):697-708. PubMed ID: 10652049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodialysis-associated beta 2M amyloidosis: current controversies.
    Stein G; Sperschneider H; Fünfstück R; Ritz E
    Nephrol Dial Transplant; 1994; 9 Suppl 3():48-50. PubMed ID: 8072726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis.
    Niwa T; Katsuzaki T; Miyazaki S; Momoi T; Akiba T; Miyazaki T; Nokura K; Hayase F; Tatemichi N; Takei Y
    Kidney Int; 1997 Jan; 51(1):187-94. PubMed ID: 8995733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.
    Miyata T; Taneda S; Kawai R; Ueda Y; Horiuchi S; Hara M; Maeda K; Monnier VM
    Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2353-8. PubMed ID: 8637877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis.
    Hou FF; Chertow GM; Kay J; Boyce J; Lazarus JM; Braatz JA; Owen WF
    Kidney Int; 1997 May; 51(5):1514-9. PubMed ID: 9150467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta 2-microglobulin serum concentration and associated amyloidosis in dialysis patients.
    Stein G; Schneider A; Thoss K; Ritz E; Schaefer K; Hüller M; Sperschneider H; Marzoll I
    Nephrol Dial Transplant; 1991; 6 Suppl 3():57-61. PubMed ID: 1775270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.